Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

1699274

registered interest
date	27/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Physician Associates
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, further to the Written Answer by Lord Markham on 25 March (HL2978), why they have specified how physician associates (PAs) are to be used, specifically with undifferentiated patients, rather than allowing GP practices to make their own decisions about the use of PAs.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL3652
answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>Physician Associates (PAs) work within a defined scope of practice and limits of competence. NHS England has provided recent guidance on the use of PAs in general practice (GP) teams. As set out in the Network Contract Directed Enhanced Service, PAs should be adequately supervised by a GP when providing care for undifferentiated patients.</p><p>In terms of employment choices, GPs are self-employed contractors to the National Health Service, and it is largely up to employers to determine how best to staff their primary care network or GP, to best meet the needs of their population.</p> answering member printed Lord Markham question first answered 05/04/2024 13:32:33 answering member 4948 label Biography information for Lord Markham
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1699317

registered interest
date	27/03/2024
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Fertilisers
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what consideration they have given to the regulation, or other oversight, of the sale of plant biostimulants, including consideration of their efficacy, safety and ecological impacts.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL3653
answer	answer is ministerial correction date of answer 12/04/2024 answer text <p>The existing UK regulatory regime for the manufacture and placing of fertilisers on the market in the UK is fragmented and in need of modernisation. There are currently no specific requirements for plant biostimulants in domestic fertilisers legislation. However, Defra intends to improve on this by consolidating and streamlining the statute book and putting in place a conformity assessment framework for fertilisers. The framework will smooth the route to market for new and innovative products which are less polluting to the environment or are less resource intensive in their creation.</p><p>To support reform of fertilisers legislation Defra has funded a review of the evidence for the safe and effective use of plant biostimulants and a review of methods for evaluating methods for verifying the efficacy of plant biostimulants.</p><p>The potential impact of a chemical on plant health, including soil microbiomes is already considered, as appropriate, as part of HSE’s robust risk assessment process for pesticides and for biocides. In our regulatory programmes we do not assess the impacts of chemicals specifically on human and animal microbiomes and are not currently considering the introduction of such measures.</p> answering member printed Lord Douglas-Miller question first answered 12/04/2024 10:10:43 answering member 5006 label Biography information for Lord Douglas-Miller
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1699318

registered interest
date	27/03/2024
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Chemicals: Regulation
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the case for incorporating into pharmaceutical, pesticide and other chemical regulation consideration of impacts on human, animal, plant and soil microbiomes.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL3654
answer	answer is ministerial correction date of answer 09/04/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) operates a robust programme of regulating and monitoring medicines to ensure patients have access to safe and effective medicines. While the microbiome is still an evolving field, the MHRA is working to further our understanding on the impact of pharmaceuticals on the microbiome. Experts in MHRA are leading on international efforts to improve understanding of this area, for example through the development of World Health Organisation reference reagents for the microbiome.</p><p> </p><p>The potential impact of a chemical on plant health, including soil microbiomes is already considered, as appropriate, as part of the Health and Safety Executive (HSE)’s robust risk assessment process for pesticides and for biocides.</p><p> </p><p>The legislation around veterinary medicines makes it clear that when considering the authorisation of antimicrobial substances for use in animals, there should be consideration of the impacts on the human, target animal, and environmental microbiomes, including plants and soils.</p> answering member printed Lord Douglas-Miller question first answered 09/04/2024 11:12:25 answering member 5006 label Biography information for Lord Douglas-Miller
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1695946

registered interest
date	13/03/2024
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Chemicals: Health Hazards
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what processes the Environment Agency follows in identifying and nominating chemical substances to the Prioritisation and Early Warning System (PEWS) for chemicals of emerging concern; and whether there are routes for individuals or other organisations to raise chemical substances of concern to PEWS.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL3231
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>The Environment Agency has developed a nomination process that integrates horizon scanning, environmental monitoring, and international collaboration. Nominations are received from internal and external stakeholders, collected from systematic reviews of published research, and watchlists developed by international environmental agency counterparts.</p><p> </p><p>Individuals and organisations are able to feed into the nomination process by raising chemical substances of concern to any contact within DEFRA or the Environment Agency via <a href="mailto:PEWS@environment-agency.gov.uk" target="_blank">PEWS@environment-agency.gov.uk</a> who can nominate the substance following the instructions provided on the internal intranet page for PEWS.</p><p> </p><p>The Environment Agency has adopted recommendations made by the Hazardous Substances Advisory Committee on stakeholder engagement, from their 2021 review of PEWS.</p> answering member printed Lord Douglas-Miller question first answered 21/03/2024 17:06:13 answering member 5006 label Biography information for Lord Douglas-Miller
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1695948

registered interest
date	13/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Professions
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government, following the protection of the titles “physician associate” and “anaesthesia associate” under the Anaesthesia Associates and Physician Associates Order 2024, when they plan to provide protection for other medical titles which are not already protected.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL3233
answer	answer is ministerial correction date of answer 25/03/2024 answer text <p>All healthcare professional regulators have protected titles relating to the professions they regulate. There are currently 64 protected titles across 10 professional health and care regulators. The Government’s regulatory reform programme, which is already underway, will consider protected titles more broadly.</p> answering member printed Lord Markham question first answered 25/03/2024 12:06:32 answering member 4948 label Biography information for Lord Markham
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1693160

registered interest
date	04/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Physician Associates
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government why the NHS England’s Network Contract Directed Enhanced Service specifies that physician associates employed under the Additional Roles Reimbursement Scheme have key responsibility for providing first point of contact care for patients presenting with undifferentiated, undiagnosed problems.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL2978
answer	answer is ministerial correction date of answer 25/03/2024 answer text <p>Physician Associates have been part of the National Health Service workforce for a number of years. They are an important part of clinical teams across the NHS, providing support to thousands of patients every day, under the supervision of doctors.</p><p>The Additional Roles Reimbursement Scheme provides funding for a number of additional roles, including Physician Associates, to help create bespoke, multi-disciplinary teams. All these roles are in place to assist general practice (GP) doctors in reducing their workload and assisting patients directly with their needs, allowing doctors to focus on more complex patients and other priorities, including continuity of care. Physician Associates work alongside GPs and the wider practice team to provide care as part of the multidisciplinary team.</p> answering member printed Lord Markham question first answered 25/03/2024 12:07:11 answering member 4948 label Biography information for Lord Markham
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1693078

registered interest
date	01/03/2024
answering body	Department for Business and Trade
answering dept id	214
answering dept short name	Business and Trade
answering dept sort name	Business and Trade
hansard heading	INEOS: Ethylene
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the environmental impact of the 1,450 kilo-tons of ethylene that will be produced by the Ineos company's 'Project One' each year; what assurances they have received from Ineos about its claim only 10 per cent of the ethylene produced will be used for single-use products; what steps they are taking to ensure that the 10-per-cent limit is not exceeded; and what penalties will be applied if the 10-per-cent limit is exceeded.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL2934
answer	answer is ministerial correction date of answer 22/03/2024 answer text <p>UKEF undertakes due diligence to ensure that all projects it supports align with robust international Environmental, Social and Human Rights standards. This includes ongoing monitoring to ensure this remains the case throughout the duration of UKEF’s support. UKEF does not attach specific conditions on the end-use of products. Further details about this individual project can be found online at: <a href="https://www.gov.uk/government/publications/category-a-project-supported-ineos-project-one-belgium/category-a-project-supported-ineos-project-one-belgium" target="_blank">Category A project supported: INEOS Project One, Belgium - GOV.UK (www.gov.uk)</a></p> answering member printed Lord Offord of Garvel question first answered 22/03/2024 12:08:52 answering member 4931 label Biography information for Lord Offord of Garvel
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle